Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1993 Jan;39:119-20, 123-6.

Treating non-insulin-dependent diabetes. Oral agents or insulin?

A H Shlossberg 1
PMCID: PMC2379577  PMID: 8435549

Abstract

This article describes suggested treatment regimens for non-insulin-dependent diabetes mellitus. Diet is usually the first-line therapy. If this fails, most patients should be given a trial of oral agents, usually sulfonylurea first. Sulfonylurea and metformin can be combined if necessary. If oral agents fail, insulin is indicated. Insulin and an oral agent sometimes are used together.

Full text

PDF
119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti K. G., Gries F. A. Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med. 1988 Apr;5(3):275–281. doi: 10.1111/j.1464-5491.1988.tb00984.x. [DOI] [PubMed] [Google Scholar]
  2. DeFronzo R. A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991 Mar;14(3):173–194. doi: 10.2337/diacare.14.3.173. [DOI] [PubMed] [Google Scholar]
  3. Galloway J. A. Treatment of NIDDM with insulin agonists or substitutes. Diabetes Care. 1990 Dec;13(12):1209–1239. doi: 10.2337/diacare.13.12.1209. [DOI] [PubMed] [Google Scholar]
  4. Genuth S. Insulin use in NIDDM. Diabetes Care. 1990 Dec;13(12):1240–1264. doi: 10.2337/diacare.13.12.1240. [DOI] [PubMed] [Google Scholar]
  5. Hermann L. S. Biguanides and sulfonylureas as combination therapy in NIDDM. Diabetes Care. 1990 Aug;13 (Suppl 3):37–41. doi: 10.2337/diacare.13.3.37. [DOI] [PubMed] [Google Scholar]
  6. Hirsch I. B., Farkas-Hirsch R., Skyler J. S. Intensive insulin therapy for treatment of type I diabetes. Diabetes Care. 1990 Dec;13(12):1265–1283. doi: 10.2337/diacare.13.12.1265. [DOI] [PubMed] [Google Scholar]
  7. Klein R., Klein B. E., Anderson S., Moss S. E. Hypoglycemic therapy in patients diagnosed to have diabetes at 30 years of age or older. J Chronic Dis. 1984;37(3):159–165. doi: 10.1016/0021-9681(84)90143-7. [DOI] [PubMed] [Google Scholar]
  8. Melander A., Lebovitz H. E., Faber O. K. Sulfonylureas. Why, which, and how? Diabetes Care. 1990 Aug;13 (Suppl 3):18–25. doi: 10.2337/diacare.13.3.18. [DOI] [PubMed] [Google Scholar]
  9. Nathan D. M., Roussell A., Godine J. E. Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study. Ann Intern Med. 1988 Mar;108(3):334–340. doi: 10.7326/0003-4819-108-3-334. [DOI] [PubMed] [Google Scholar]
  10. Rossetti L., Giaccari A., DeFronzo R. A. Glucose toxicity. Diabetes Care. 1990 Jun;13(6):610–630. doi: 10.2337/diacare.13.6.610. [DOI] [PubMed] [Google Scholar]
  11. Schnack C., Prager R. J., Winkler J., Klauser R. M., Schneider B. G., Schernthaner G. Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care. 1989 Sep;12(8):537–543. doi: 10.2337/diacare.12.8.537. [DOI] [PubMed] [Google Scholar]
  12. Selam J. L., Charles M. A. Devices for insulin administration. Diabetes Care. 1990 Sep;13(9):955–979. doi: 10.2337/diacare.13.9.955. [DOI] [PubMed] [Google Scholar]
  13. Turner R. C., Holman R. R. Insulin use in NIDDM. Rationale based on pathophysiology of disease. Diabetes Care. 1990 Sep;13(9):1011–1020. doi: 10.2337/diacare.13.9.1011. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES